8,000-Patient study aims to perfect Scope-Based cancer prevention
NCT ID NCT01750619
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 8,000 people who are having precancerous or early cancerous growths in their digestive tract removed using a scope (endoscope). The goal is to see how often the procedure completely removes the lesion and to track any complications like bleeding or infection. By collecting this real-world data, doctors hope to improve techniques and better understand long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN NEOPLASM OF INTESTINAL TRACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Interventional Endoscopy Services
RECRUITINGSan Francisco, California, 94115, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug velzatinib tested for Hard-to-Treat stomach and intestinal tumors
- Can a digital Pre-Surgery boost help cancer patients recover faster?
- New hope for advanced colon cancer: which drug combo works best?
- Massive cancer registry aims to unlock better GI cancer care
- Blood test could spot returning colon cancer months before scans
- New combo aims to fix Chemo's lingering side effect in cancer survivors